Placeholder Banner

Testimony of John F. Crowley, Executive Chairman of Amicus Therapeautics, to the House Committee on Energy and Commerce Subcommittee on Oversight and Investigations  for the hearing “How the IRA’s Price Setting Scheme Means Fewer Cures for Patients”

September 20, 2023

BIO Board Vice Chair and CEO of Amicus Therapeutics testified that the drug price controls in the Inflation Reduction Act harm drug research and development.

Download Full Comments Below
Discover More
BIO provided general comments and recommended edits Re: FDA-2023-D-3031
BIO joins 30 other national trade associations in speaking out against unprecedented and burdensome FTC-DOJ regulation of mergers
BIO submits comments in response to the agency’s request for information (FDA-2023-N-3742)